Exome Sequence Identifies RIPK4 As the Bartsocas-Papas Syndrome Locus
Overview
Authors
Affiliations
Pterygium syndromes are complex congenital disorders that encompass several distinct clinical conditions characterized by multiple skin webs affecting the flexural surfaces often accompanied by craniofacial anomalies. In severe forms, such as in the autosomal-recessive Bartsocas-Papas syndrome, early lethality is common, complicating the identification of causative mutations. Using exome sequencing in a consanguineous family, we identified the homozygous mutation c.1127C>A in exon 7 of RIPK4 that resulted in the introduction of the nonsense mutation p.Ser376X into the encoded ankyrin repeat-containing kinase, a protein that is essential for keratinocyte differentiation. Subsequently, we identified a second mutation in exon 2 of RIPK4 (c.242T>A) that resulted in the missense variant p.Ile81Asn in the kinase domain of the protein. We have further demonstrated that RIPK4 is a direct transcriptional target of the protein p63, a master regulator of stratified epithelial development, which acts as a nodal point in the cascade of molecular events that prevent pterygium syndromes.
Rare variants in cause Van der Woude syndrome and other features of peridermopathy.
Robinson K, Robinson K, Singh S, Walkup R, Fawwal D, Adeyemo W medRxiv. 2025; .
PMID: 39867391 PMC: 11759255. DOI: 10.1101/2025.01.17.25320742.
Lysophosphatidic acid down-regulates human RIPK4 mRNA in keratinocyte- derived cell lines.
Xu L, Bajorski P, Poligone B PLoS One. 2024; 19(4):e0287444.
PMID: 38630705 PMC: 11023271. DOI: 10.1371/journal.pone.0287444.
Functions of the RIP kinase family members in the skin.
Urwyler-Rosselet C, Tanghe G, Devos M, Hulpiau P, Saeys Y, Declercq W Cell Mol Life Sci. 2023; 80(10):285.
PMID: 37688617 PMC: 10492769. DOI: 10.1007/s00018-023-04917-2.
Anthwal N, Urban D, Sadier A, Takenaka R, Spiro S, Simmons N BMC Biol. 2023; 21(1):101.
PMID: 37143038 PMC: 10161559. DOI: 10.1186/s12915-023-01598-y.
Vemurafenib and Dabrafenib Downregulates RIPK4 Level.
Madej E, Brozyna A, Adamczyk A, Wronski N, Harazin-Lechowska A, Muzyk A Cancers (Basel). 2023; 15(3).
PMID: 36765875 PMC: 9913565. DOI: 10.3390/cancers15030918.